(Q54331204)

27 May 2018

title

Alterations of insulin-like growth factor-1 receptor gene copy number and protein expression are common in non-small cell lung cancer. (English)

1 reference

27 May 2018

author

Bing Yu

3

1 reference

27 May 2018

author name string

T N Tran

1

1 reference

27 May 2018

C I Selinger

2

1 reference

27 May 2018

C C Ng

4

1 reference

27 May 2018

M R J Kohonen-Corish

5

1 reference

27 May 2018

B McCaughan

6

1 reference

27 May 2018

C Kennedy

7

1 reference

27 May 2018

S A O'Toole

8

1 reference

27 May 2018

W A Cooper

9

1 reference

27 May 2018

language of work or name

English

0 references

publication date

12 August 2014

1 reference

27 May 2018

Journal of Clinical Pathology

published in

1 reference

27 May 2018

volume

67

1 reference

27 May 2018

issue

11

1 reference

27 May 2018

page(s)

985-991

1 reference

27 May 2018

cites work

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Ras, PI(3)K and mTOR signalling controls tumour cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Insulin-like growth factor receptor inhibitors: baby or the bathwater?

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Fibroblast growth factor receptor 1 (FGFR1) copy number is an independent prognostic factor in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Tissue microarray validation: a methodologic study with special reference to lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

High expression levels of total IGF-1R and sensitivity of NSCLC cells in vitro to an anti-IGF-1R antibody (R1507)

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Patterns of DNA mutations and ALK rearrangement in resected node negative lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Increased insulin-like growth factor 1 receptor protein expression and gene copy number in small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJCLINPATH-2014-202347

10.1136/JCLINPATH-2014-202347

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018